Clinical Toolkit

If you are looking for resources for you or your staff to learn more about having effective conversations with patients about latent TB, these may help:

• NPTC Formulary Brief (2019) - Tuberculosis Treatment [PDF - 175 KB]
• NPTC Formulary Brief (2013) - Rifapentine [PDF - 120 KB]
• H.S. Chest Clinic Guidelines
• Pharmacy Policy/Procedure Template- 3HP Directly Observed Therapy
• H.R. Template for 3HP Treatment - Templates
• Latent TB Screening & Treatment Quick Reference Card
• Latent TB Cascade of Care
• CDC Slide Set:
  • Targeted Tuberculosis (TB) Testing and Treatment of Latent TB Infection Exit Disclaimer: You Are Leaving www.ihs.gov 
• MMWR Recommendations (5/2019):
  • Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Exit Disclaimer: You Are Leaving www.ihs.gov 
  • Recommendations from the National Tuberculosis Controllers Association and CDC, 2019 Exit Disclaimer: You Are Leaving www.ihs.gov 
• CDC Fact Sheets: Screening/Diagnosis
  • Targeted Tuberculosis Testing & Interpreting Tuberculin Skin Test Results, 2019 Exit Disclaimer: You Are Leaving www.ihs.gov 
• CDC Fact Sheets: Treatment
  • Treatment Options for Latent Tuberculosis Infection, 2019 Exit Disclaimer: You Are Leaving www.ihs.gov 
  • Treatment of Latent Tuberculosis Infection: Maximizing Adherence Exit Disclaimer: You Are Leaving www.ihs.gov 
• National Tuberculosis Controller Association: Provider Guidance
  • Using the Isoniazid/Rifapentine to Treat Latent Tuberculosis Infection Exit Disclaimer: You Are Leaving www.ihs.gov 

Examples of resources for providers to share with patients include:

• CDC Fact Sheets- Patient Education
  • Testing for Tuberculosis (TB) Exit Disclaimer: You Are Leaving www.ihs.gov 
  • What You Need to Know About Your Medicine for Latent Tuberculosis Infection (TB) Exit Disclaimer: You Are Leaving www.ihs.gov Infection: Isoniazid and Rifapentine Exit Disclaimer: You Are Leaving www.ihs.gov 
• Infographic- Patient Education
  • Patient Information: The 12-dose Regimen for Latent Tuberculosis (TB) Infection Exit Disclaimer: You Are Leaving www.ihs.gov 
  • Medication Tracker: The 12-dose Regimen for Latent Tuberculosis (TB) Infection Exit Disclaimer: You Are Leaving www.ihs.gov 

Videos

• Latent TB Videos for Healthcare Providers: Online Video Series (UCSF) Exit Disclaimer: You Are Leaving www.ihs.gov 

  This series of three videos aims to help providers talk to their patients about latent TB infection testing and treatment. Each of the videos are two-minutes long. The topics covered include;

• Why Should I Get Testing for Latent TB? Exit Disclaimer: You Are Leaving www.ihs.gov 
• Why Do I Need Treatment for Latent TB?

If you would like posters to display in your office, here are some that may be helpful:

• Stop TB Exit Disclaimer: You Are Leaving www.ihs.gov 
• Think TB Exit Disclaimer: You Are Leaving www.ihs.gov 

If you have any questions, please contact the NPTC at IHSNPTC1@ihs.gov.